vimarsana.com

தொழில்நுட்பம் சங்கம் ஆஃப் ஆஸ்திரேலியா News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Approval processes to be scrutinised for new drugs and medical technologies

Date Time Approval processes to be scrutinised for new drugs and medical technologies On Thursday 11 and Friday 12 March 2021 the House of Representatives Standing Committee on Health, Aged Care and Sport will hold two days of public hearings in Sydney as part of the Committee’s ongoing inquiry into approval processes for new drugs and novel medical technologies in Australia. The Committee will hear evidence from numerous stakeholders including patient advocacy groups, clinician and research bodies, and industry. Witnesses will include rare disease advocates from Rare Voices Australia, and representatives from the Medical Technology Association of Australia. The program for the hearings is available at the Committee’s website.

Aussies may pay more for lifesaving hip, knee devices

Exclusive: Health fund members could face exorbitant out of pocket expenses for devices like hip and knee replacements, stents and pacemakers under major reforms being considered by the federal government. And from 2022 surgeons could also be stopped from selecting the best medical devices to treat their patients, manufacturers of the products claim. At present health funds have to reimburse the full cost of any medical device on the government s prostheses list but Australians are being massively overcharged. Private patients pay double the price of those overseas and 45 per cent more than public hospitals.     The changes have been proposed by the Department of Health and private insurers ahead of the May budget which could see an average price set for medical devices.

BPH Energy Limited (ASX:BPH) Cortical Dynamics Patent and Advisory Panel Appoint Update

BPH Energy Limited (ASX:BPH) Cortical Dynamics Patent and Advisory Panel Appoint Update    Cortical Dynamics Patent and Advisory Panel Appoint UpdatePerth, Jan 22, 2021 AEST (ABN Newswire) - BPH Energy Ltd ( ASX:BPH) investee company Cortical Dynamics Ltd ( Cortical ) is pleased to announce the issuance of European Patent Number 2088924 Neurodiagnostic Monitoring and display System in Belgium, France, Germany and United Kingdom. Cortical has developed an extensive patent portfolio encapsulating the BARM, providing critical patent protection across a number of key brain monitoring markets. Corticals competitive advantage is underpinned by a strong patent position covered by six patent families and 26 granted patents. Currently, Cortical has patents awarded in Australia, New Zealand, Japan, the People s Republic of China, Europe and the United States.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.